168 related articles for article (PubMed ID: 33770721)
1. Simple new method for labelling of PSMA-11 with
Urbanová K; Seifert D; Vinšová H; Vlk M; Lebeda O
Appl Radiat Isot; 2021 Jun; 172():109692. PubMed ID: 33770721
[TBL] [Abstract][Full Text] [Related]
2. Optimization of Labeling PSMA
Eppard E; Homann T; de la Fuente A; Essler M; Rösch F
J Nucl Med; 2017 Mar; 58(3):432-437. PubMed ID: 28082433
[TBL] [Abstract][Full Text] [Related]
3. Cold Kit for Prostate-Specific Membrane Antigen (PSMA) PET Imaging: Phase 1 Study of
Hofman MS; Eu P; Jackson P; Hong E; Binns D; Iravani A; Murphy D; Mitchell C; Siva S; Hicks RJ; Young JD; Blower PJ; Mullen GE
J Nucl Med; 2018 Apr; 59(4):625-631. PubMed ID: 28986512
[No Abstract] [Full Text] [Related]
4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of SnO2-based 68Ge/68Ga generator and aspects of radiolabelling DOTA-peptides.
de Blois E; Sze Chan H; Naidoo C; Prince D; Krenning EP; Breeman WA
Appl Radiat Isot; 2011 Feb; 69(2):308-15. PubMed ID: 21145751
[TBL] [Abstract][Full Text] [Related]
6. Validation of a [Al
Al-Momani E; Israel I; Samnick S
Appl Radiat Isot; 2017 Dec; 130():102-108. PubMed ID: 28950199
[TBL] [Abstract][Full Text] [Related]
7. Hybrid Chelator-Based PSMA Radiopharmaceuticals: Translational Approach.
Lahnif H; Grus T; Pektor S; Greifenstein L; Schreckenberger M; Rösch F
Molecules; 2021 Oct; 26(21):. PubMed ID: 34770742
[TBL] [Abstract][Full Text] [Related]
8. Radiohybrid Ligands: A Novel Tracer Concept Exemplified by
Wurzer A; Di Carlo D; Schmidt A; Beck R; Eiber M; Schwaiger M; Wester HJ
J Nucl Med; 2020 May; 61(5):735-742. PubMed ID: 31862804
[TBL] [Abstract][Full Text] [Related]
9. Preparation of [(68)Ga]PSMA-11 for PET-CT imaging using a manual synthesis module and organic matrix based (68)Ge/(68)Ga generator.
Nanabala R; Anees MK; Sasikumar A; Joy A; Pillai MR
Nucl Med Biol; 2016 Aug; 43(8):463-9. PubMed ID: 27231953
[TBL] [Abstract][Full Text] [Related]
10. Prospective Comparison of 18F-Fluoromethylcholine Versus 68Ga-PSMA PET/CT in Prostate Cancer Patients Who Have Rising PSA After Curative Treatment and Are Being Considered for Targeted Therapy.
Morigi JJ; Stricker PD; van Leeuwen PJ; Tang R; Ho B; Nguyen Q; Hruby G; Fogarty G; Jagavkar R; Kneebone A; Hickey A; Fanti S; Tarlinton L; Emmett L
J Nucl Med; 2015 Aug; 56(8):1185-90. PubMed ID: 26112024
[TBL] [Abstract][Full Text] [Related]
11. Automated production of [
Garcia-Arguello SF; Lopez-Lorenzo B; Ruiz-Cruces R
J Labelled Comp Radiopharm; 2019 Mar; 62(3):146-153. PubMed ID: 30672007
[TBL] [Abstract][Full Text] [Related]
12. Simple, mild, one-step labelling of proteins with gallium-68 using a tris(hydroxypyridinone) bifunctional chelator: a
Nawaz S; Mullen GED; Sunassee K; Bordoloi J; Blower PJ; Ballinger JR
EJNMMI Res; 2017 Oct; 7(1):86. PubMed ID: 29067565
[TBL] [Abstract][Full Text] [Related]
13. Purification and labeling strategies for (68)Ga from (68)Ge/ (68)Ga generator eluate.
Mueller D; Klette I; Baum RP
Recent Results Cancer Res; 2013; 194():77-87. PubMed ID: 22918755
[TBL] [Abstract][Full Text] [Related]
14. In Vitro and In Vivo Characterization of an
Lütje S; Franssen GM; Herrmann K; Boerman OC; Rijpkema M; Gotthardt M; Heskamp S
J Nucl Med; 2019 Jul; 60(7):1017-1022. PubMed ID: 30655329
[TBL] [Abstract][Full Text] [Related]
15. Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancer.
Afshar-Oromieh A; Zechmann CM; Malcher A; Eder M; Eisenhut M; Linhart HG; Holland-Letz T; Hadaschik BA; Giesel FL; Debus J; Haberkorn U
Eur J Nucl Med Mol Imaging; 2014 Jan; 41(1):11-20. PubMed ID: 24072344
[TBL] [Abstract][Full Text] [Related]
16. Effects of Linker Modification on Tumor-to-Kidney Contrast of
Kuo HT; Pan J; Zhang Z; Lau J; Merkens H; Zhang C; Colpo N; Lin KS; Bénard F
Mol Pharm; 2018 Aug; 15(8):3502-3511. PubMed ID: 29920108
[No Abstract] [Full Text] [Related]
17. Radiofluorination of PSMA-HBED via Al(18)F(2+) Chelation and Biological Evaluations In Vitro.
Malik N; Baur B; Winter G; Reske SN; Beer AJ; Solbach C
Mol Imaging Biol; 2015 Dec; 17(6):777-85. PubMed ID: 25869080
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and pre-clinical evaluation of a new class of high-affinity
Kelly J; Amor-Coarasa A; Nikolopoulou A; Kim D; Williams C; Ponnala S; Babich JW
Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):647-661. PubMed ID: 27847991
[TBL] [Abstract][Full Text] [Related]
19. On-cartridge preparation and evaluation of
Socan A; Petrik M; Kolenc Peitl P; Krošelj M; Rangger C; Novy Z; Svajger U; Gmeiner T; Decristoforo C
Nucl Med Biol; 2019 Apr; 71():23-31. PubMed ID: 31128475
[TBL] [Abstract][Full Text] [Related]
20. Clinical Translation and First In-Human Use of [
Eppard E; de la Fuente A; Benešová M; Khawar A; Bundschuh RA; Gärtner FC; Kreppel B; Kopka K; Essler M; Rösch F
Theranostics; 2017; 7(18):4359-4369. PubMed ID: 29158832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]